Literature DB >> 10074158

T cells contribute to disease severity during coxsackievirus B4 infection.

A I Ramsingh1, W T Lee, D N Collins, L E Armstrong.   

Abstract

By using a model of coxsackievirus B4-induced disease, the question of whether tissue damage is due to the virus or to immune-mediated mechanisms was addressed. Both viral replication and T-cell function were implicated in contributing to the severity of disease. Three stages (I to III) of disease, which correspond to periods of high viral titers, low viral titers, and no infectious virus, have been identified. Stage I disease is considered to be primarily the result of viral replication. Immunopathological mechanisms appear to contribute to the severity of stage II and III disease. To investigate the role of T cells in contributing to the severity of disease, viral infection in CD8 knockout (ko) mice and CD4 ko mice was analyzed. CD8 T-cell responses appear to be beneficial during early, viral disease but detrimental in later disease when viral titers are diminishing. CD4 ko mice, unlike the parental strain, survived infection. Viral replication was lower in the CD4 ko mice. Was survival due to decreased viral replication or to the lack of T-helper-cell function? To investigate further the role of T helper cells in contributing to tissue damage, viral infection in two additional ko strains (interleukin-4 [IL-4] ko and gamma interferon ko strains) was examined. A clear correlation between viral replication and the outcome of infection was not observed. The absence of IL-4, which may influence T-helper-cell subset development, was advantageous during early viral disease but deleterious in later disease. The results suggest that T-cell-mediated immunity is both beneficial and detrimental during coxsackievirus B4 infection.

Entities:  

Mesh:

Year:  1999        PMID: 10074158      PMCID: PMC104068     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

Review 1.  Coxsackieviruses and pancreatitis.

Authors:  A I Ramsingh
Journal:  Front Biosci       Date:  1997-08-15

Review 2.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 3.  Genetics of coxsackievirus B cardiovirulence and inflammatory heart muscle disease.

Authors:  S Tracy; N M Chapman; J Romero; A I Ramsingh
Journal:  Trends Microbiol       Date:  1996-05       Impact factor: 17.079

4.  Murine natural killer cells limit coxsackievirus B3 replication.

Authors:  E K Godeny; C J Gauntt
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

5.  Coxsackievirus B-3-induced myocarditis. Effect of sex steroids on viremia and infectivity of cardiocytes.

Authors:  D C Lyden; J Olszewski; M Feran; L P Job; S A Huber
Journal:  Am J Pathol       Date:  1987-03       Impact factor: 4.307

6.  Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to Coxsackievirus B3-induced myocarditis.

Authors:  N Neu; K W Beisel; M D Traystman; N R Rose; S W Craig
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

7.  Severity of disease induced by a pancreatropic Coxsackie B4 virus correlates with the H-2Kq locus of the major histocompatibility complex.

Authors:  A Ramsingh; J Slack; J Silkworth; A Hixson
Journal:  Virus Res       Date:  1989-12       Impact factor: 3.303

Review 8.  Clinical and experimental aspects of viral myocarditis.

Authors:  K Leslie; R Blay; C Haisch; A Lodge; A Weller; S Huber
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

9.  Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies.

Authors:  H M Cherwinski; J H Schumacher; K D Brown; T R Mosmann
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

10.  Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis.

Authors:  L J Wolfgram; K W Beisel; N R Rose
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  9 in total

1.  Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.

Authors:  S Tracy; K M Drescher; N M Chapman; K-S Kim; S D Carson; S Pirruccello; P H Lane; J R Romero; J S Leser
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 2.  Type B coxsackieviruses and their interactions with the innate and adaptive immune systems.

Authors:  Christopher C Kemball; Mehrdad Alirezaei; J Lindsay Whitton
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

3.  beta2-microglobulin-associated regulation of interferon-gamma and virus-specific immunoglobulin G confer resistance against the development of chronic coxsackievirus myocarditis.

Authors:  Karin Klingel; Jens-Jörg Schnorr; Martina Sauter; Gudrun Szalay; Reinhard Kandolf
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

4.  Dynamics of molecular responses to coxsackievirus B4 infection differentiate between resolution and progression of acute pancreatitis.

Authors:  Rui Gu; Anae Shampang; Andrew Reilly; Dusti Fisher; William Glass; Arlene I Ramsingh
Journal:  Virology       Date:  2012-03-11       Impact factor: 3.616

5.  Progression or resolution of coxsackievirus B4-induced pancreatitis: a genomic analysis.

Authors:  Stephanie E Ostrowski; Andrew A Reilly; Doris N Collins; Arlene I Ramsingh
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

6.  Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responses.

Authors:  Rui Gu; Anae Shampang; Toufic Nashar; Manisha Patil; Deborah H Fuller; Arlene I Ramsingh
Journal:  PLoS One       Date:  2010-09-02       Impact factor: 3.240

7.  Exogenous interleukin-12 protects against lethal infection with coxsackievirus B4.

Authors:  Daniel M Potvin; Dennis W Metzger; William T Lee; Doris N Collins; Arlene I Ramsingh
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

8.  IL-10 is pathogenic during the development of coxsackievirus B4-induced chronic pancreatitis.

Authors:  Rui Gu; Anae Shampang; Andrew Reilly; Dusti Fisher; William Glass; Arlene I Ramsingh
Journal:  Virology       Date:  2009-10-01       Impact factor: 3.616

9.  Dendritic cells and regulatory T cells expressing CCR4 provide resistance to coxsackievirus B5-induced pancreatitis.

Authors:  Marcela C S Françozo; Frederico R C Costa; Isabel C Guerra-Gomes; João S Silva; Renata Sesti-Costa
Journal:  Sci Rep       Date:  2019-10-14       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.